William M.
- Country
- Italy
- Department
- Pediatric Nephrology, Dialysis and Transplant Unit
Research Overview
- Safety Evaluation of Long-term Finerenone with ACE Inhibitor or Angiotensin Receptor Blocker in Pediatric Chronic Kidney Disease with Proteinuria
- Evaluation of Finerenone in Combination with ACEI or ARB for Proteinuria and Chronic Kidney Disease in Pediatric Patients: A Randomized, Double-Blind, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 66 of 66 partner sites.
Specializations
Pediatric Nephrology
The investigator specializes in treating chronic kidney disease in pediatric and young adult populations, with particular emphasis on managing conditions affecting children aged 1 to 18 years.
- Pediatric renal disorders
- Proteinuria management
- Long-term kidney care
Their research focuses on innovative therapeutic approaches for young patients with kidney-related conditions.
Therapeutic Innovation
The investigator explores new treatment combinations involving ACE inhibitors and angiotensin receptor blockers for pediatric kidney disorders.
- Novel therapeutic combinations
- Protein excretion reduction
- Treatment optimization
Their work aims to advance treatment options for children with chronic renal conditions.
Clinical Safety Assessment
The investigator evaluates the long-term safety and efficacy of treatments for pediatric kidney disorders, particularly focusing on extended therapeutic interventions.
- Safety monitoring
- Long-term outcomes
- Treatment effectiveness
Their research emphasizes comprehensive safety assessment in pediatric populations with renal conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.